Epigenetic gene silencing in the Wnt pathway in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Breast cancer remains a leading malignancy in women, with its complete molecular underpinnings still under investigation.
• While endocrine therapies have advanced, the transformation process involves genetic and epigenetic changes.
• The wingless and integration site growth factor (Wnt) pathway is frequently dysregulated in breast cancer.

Purpose of the Study:

• To review the role of epigenetic regulation in the Wnt pathway in breast cancer.
• To highlight DNA hypermethylation as a key mechanism driving Wnt pathway dysregulation in breast cancer.
• To differentiate Wnt pathway alterations in breast cancer from those in other cancers like colorectal cancer.

Main Methods:

• Literature review focusing on epigenetic modifications and Wnt pathway signaling in breast cancer.
• Analysis of studies investigating DNA methylation patterns in breast cancer tissues.
• Synthesis of current research on the impact of aberrant Wnt pathway regulation on breast cancer development.

Main Results:

• Genetic mutations in Wnt pathway components are less common in breast cancer compared to colorectal cancer.
• DNA hypermethylation is identified as a predominant mechanism for Wnt pathway dysregulation in breast cancer.
• Aberrant epigenetic regulation of Wnt pathway components contributes to breast cancer pathogenesis.

Conclusions:

• Epigenetic dysregulation, particularly DNA hypermethylation, is crucial for Wnt pathway alterations in breast cancer.
• Understanding these epigenetic mechanisms is vital for developing novel therapeutic strategies for breast cancer.
• This review underscores the significance of epigenetics in breast cancer molecular biology.